The V3 region of gp120 is responsible for anti-HIV-1 activity of heparin sulphate

Acta Biochimica Polonica

Volumn 45, Issue 3, 1998, Pages 799-804

  Jagodzinski, Paweł P ^a,b   Trzeciak, Wiesław H ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

CD4+ lymphocytes; Heparin sulphate; HIV 1 strains; V3 region

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GLYCOPROTEIN GP 120; HEPARAN SULFATE; HIV ENVELOPE PROTEIN GP120 (305 321); HIV ENVELOPE PROTEIN GP120 (305-321); PEPTIDE FRAGMENT;

ANIMAL; ARTICLE; CD4+ T LYMPHOCYTE; CELL STRAIN COS1; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; VIROLOGY;

ANIMALS; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; COS CELLS; HEPARITIN SULFATE; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; PEPTIDE FRAGMENTS;

EID: 0032254434     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.1998_4219     Document Type: Article

References (13)

1. Sattentau, Q.J. & Weiss, R.A. (1988) The CD4 antigen: Physiological ligand and HIV receptor. Cell 52, 631-633.
2. Maddon, P.J. (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333-348.
3. Hwang, S.S., Boyle, T.J., Lyerly, H.K. & Cullen, B.R. (1991) Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253, 71-74.
4. Jagodzinski, P.P., Wustner, J., Kmieciak, D., Wasik, T., Fertała, A., Sieron, L.A., Takahashi, M., Tsuji, T., Mimura, T., Fung, M.S., Gorny, M.K., Kloczewiak, M., Kaneko, Y. & Kozbor, D. (1996) Role of the V2, V3 and CD4-binding domains of gp120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes. Virology 226, 217-227.
5. Baba, M., Schols, D., Pauwels, R., Nakashima, H. & De Clercq, E. (1990) Sulphated polysaccharides as potent inhibitors of HIV-induced syncytium formation: A new strategy towards AIDS chemotherapy. J. Acquir. Immune Defic. Syndr. 3, 493-499.
6. Callahan, L.N., Phelan, M., Mallinson, M. & Norcross, M.A. (1991) Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions. J. Virol. 65, 1543-1550.
7. Lederman, S.R., Gulick, R. & Chess, L. (1989) Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. J. Immunol. 143, 1149-1154.
8. Cullen, B.R. (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152, 685-705.
9. Ho, D.D., Fung, M.S., Cao, Y.Z., Li, X.L., Sun, C., Chang, T.W. & Sun, N.C. (1991) Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody. Proc. Natl. Acad. Sci. U.S.A. 88, 8949-8952.
10. Moore, J.P., Thali, M., Jameson, B.A., Vignaux, F., Lewis, G.K., Poon, S.-W., Charles, M., Fung, M.S., Sun, B., Durda, P.J., Akerblom, L., Wahren, B., Ho, D.D., Sattentau, Q.J. & Sodroski, J. (1993) Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: Probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J. Virol. 67, 4785-4796.
11. Gorny, M.K., Xu, J.Y., Karwowska, S., Buchbinder, A. & Zolla-Pazner, S. (1993) Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J. Immunol. 150, 635-643.
12. Jagodzinski, P.P., Wiaderkiewicz, R., Kurzawski, G., Kloczewiak, M., Nakashima, H., Hyjek, E., Yamamoto, N., Uryu, T., Kaneko, Y., Posner, M.R. & Kozbor, D. (1994) Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro. Virology 202, 735-745.
13. Batinic, D. & Robey, F.A. (1992) The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulphated polysaccharides and CD4-derived synthetic peptides. J. Biol. Chem. 267, 6664-6667.